Ascendis Pharma A (ASND) EBT Margin Growth (5y) (2019 - 2026)
Ascendis Pharma A (ASND) EBT Margin Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ascendis Pharma A | 15.31 Bn | 14.64 Bn | 268.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 842,322.00 |
| Dec 31, 2025 | 19,468.00 |
| Sep 30, 2025 | 438,954.00 |
| Jun 30, 2025 | 659,610.00 |
| Mar 31, 2025 | 275,649.00 |
| Dec 31, 2024 | 18,672.00 |
| Sep 30, 2024 | 95,257.00 |
| Jun 30, 2024 | 153,325.00 |
| Mar 31, 2024 | 85,797.00 |
| Dec 31, 2023 | 10,538.00 |
| Sep 30, 2023 | -33,621.00 |
| Jun 30, 2023 | 12.68 Mn |
| Mar 31, 2023 | 14.78 Mn |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 675,496.00 |
| Jun 30, 2022 | 560,322.00 |
| Mar 31, 2022 | 492,710.00 |
| Dec 31, 2021 | 142,927.00 |
| Sep 30, 2021 | -565,222.00 |
| Jun 30, 2021 | -1.20 Mn |